Element Squared LLC acquired 15,051 shares of Biogen Inc., valued at $2.65 million. Biogen exceeded earnings expectations but saw a 7.2% revenue decline. Analysts rate the stock as a "Hold" with a target price of $208.31.

NodeGuardian

2026-04-16 12:41:21

Abstract generation in progress

Element Squared LLC recently acquired 15,051 shares of Biogen Inc. (NASDAQ:BIIB) during the fourth quarter, a stake valued at approximately $2.65 million, making it their 15th largest holding. Biogen surpassed earnings expectations with an EPS of $1.99 against an estimated $1.61, though revenue decreased by 7.2% year-over-year. Analysts currently hold a “Hold” rating on Biogen stock with an average price target of $208.31.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
154.45K Popularity
#
Gate13thAnniversaryLive
421.54K Popularity
#
US-IranTalksVSTroopBuildup
774.41K Popularity
#
CryptoMarketRecovery
98K Popularity
#
WCTCTradingChallengeShare8MUSDT
626.25K Popularity

Sitemap

15,051 Shares in Biogen Inc. $BIIB Bought by Element Squared LLC

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

US-IranTalksVSTroopBuildup

CryptoMarketRecovery

WCTCTradingChallengeShare8MUSDT

Pin